Clinical Trial Update: 68Ga/177Lu-PSMA Theranostics in Recurrent Grade 3 and Grade 4 Glioma [NA]

View source ↗

Summary

This clinical trial update indicates recruitment is ongoing for a theranostic approach using 68Ga-PSMA and 177Lu-PSMA in recurrent high-grade glioma (Grade 3/4)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Drugs mentioned

• 177Lu-PSMA
• 68Ga-PSMA

Snippet

Sponsor: St. Olavs Hospital | Conditions: High Grade Glioma | NA | Status: RECRUITING